Anticoagulation Certificate
Release Date: February 24, 2021
Expiration Date: February 24, 2024
Activity Type: Application-based
CE Credit Hour(s): 32 hours
Activity Fee: $445.00/$545.00 member/non-member
Overview
This self-guided, online program will provide 32 hours of ACPE continuing education for pharmacists, incorporating recorded presentations, skill-focused activities, and supportive readings.
The modules are designed to provide focused education on anticoagulation therapy management, beginning with regulatory drivers and the concept of anticoagulation stewardship; continuing through the medications that comprise anticoagulation therapy and their use in various acute care, ambulatory, and perioperative settings; the unique needs of specialty populations; adverse effect monitoring and management; interpretation of laboratory assays and application to care, and more. Throughout the program, skills needed to be an effective anticoagulation practitioner are discussed. Case studies will be discussed in depth, with practical, real-world situations explored and approaches to treatment explained. Upon completion of all the modules, learners should be proficient in anticoagulation therapy management.
Professional Certificate Requirement
Once a learner has successfully completed the educational curriculum, he/she will have the opportunity to complete a 75 question comprehensive exam. If the learner successfully completes the exam (minimum 80% passing rate; unlimited attempts permitted), he/she will be eligible to earn the professional certificate.
Listing of the Anticoagulation Certificate Modules
|
Learning Module |
ACPE # |
Credit Hours |
|
Introduction to Anticoagulation |
0204-0000-21-714-H04-P |
2.25 |
|
Heparin, Low Molecular Weight Heparin, and Venous Thromboembolism Prophylaxis |
0204-0000-21-715-H01-P |
2.75 |
|
Arterial Disease and Venous Thromboembolism Treatment |
0204-0000-21-716-H01-P |
2.75 |
|
Thrombolytic Therapy |
0204-0000-21-717-H01-P |
2.25 |
|
Warfarin and Focus on the Ambulatory Setting |
0204-0000-21-718-H01-P |
2.75 |
|
Oral Direct Thrombin Inhibitors (DTI), Anti-Xa Agents, and Atrial Fibrillation |
0204-0000-21-719-H01-P |
2.75 |
|
Anticoagulation in Special Populations |
0204-0000-21-720-H01-P |
3.5 |
|
Mechanical Devices and Focus on the Acute Care Setting |
0204-0000-21-721-H01-P |
2.5 |
|
Heparin-Induced Thrombocytopenia: Pathophysiology and Recognition |
0204-0000-21-722-H01-P |
2.75 |
|
Laboratory Assessments |
0204-0000-21-723-H01-P |
2 |
|
Reversing Anticoagulation and Peri-Operative Management |
0204-0000-21-724-H01-P |
3.5 |
|
Skills for Managing Anticoagulation Therapy |
0204-0000-21-725-H04-P |
2.25 |